Global Digital Therapeutics Market to Grow at 16.8% During 2025-2033, Supported by Rising Incidences of Chronic Disorders

December 10, 2024 | Healthcare

According to the latest report by IMARC Group, titled “Digital Therapeutics Market Report by Application (Diabetes, Obesity, CVD, CNS Disease, Respiratory Diseases, Smoking Cessation, and Others), End Use (Patients, Providers, Payers, Employers, and Others), and Region 2025-2033,” the global digital therapeutics market size reached USD 7.1 Billion in 2024. Digital therapeutics (DTx) is a subset of cognitive-behavioral therapy that is utilized to deliver evidence-based treatment interventions to patients. It adopts various software programs, wearable devices, digital data, and an internet connection to diagnose, treat, prevent, and manage physical and mental illnesses. They find application in conditions, such as Alzheimer’s disease, type 2 diabetes, asthma, gastrointestinal problems, and chronic pulmonary disease. DTx can be used as a standalone therapy or in conjunction with conventional treatments, including in-person and pharmacological therapies, to enhance the effectiveness of health care.

Global Digital Therapeutics Market Trends:

The DTx market is majorly being driven by the rising prevalence of chronic diseases, along with the shifting inclination toward preventive treatment solutions and the increasing need to lower healthcare costs. Additionally, the inflating sales of smart devices due to the availability of high-speed internet connectivity has further led to an increase in the adoption of digital devices amongst consumers for accessible, engaging, and personalized medical solutions. This, in turn, is contributing to the market growth. Moreover, rising awareness regarding the benefits of DTx, such as patient convenience, and improved drug compliance, is acting as another growth-inducing factor. Other than this, leading pharmaceutical companies are consistently investing in research and development (R&D) activities to introduce advanced production technologies and expand their product portfolio, which is creating a positive outlook for the market. Looking forward, the market value is projected to reach USD 28.7 Billion by 2033, expanding at a CAGR of 16.8% during 2025-2033.

Market Summary:

  • Based on the application, the market has been divided into diabetes, obesity, cardiovascular disorders (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, and others.
  • On the basis of the end use, the market has been segmented into patients, providers, payers, employers, and others.
  • On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
  • The competitive landscape of the market has also been examined, with some of the key players being 2Morrow Inc., Canary Health Inc., Click Therapeutics Inc., Mango Health Inc. (TrialCard Incorporated), Noom Health Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health (ResMed), Teladoc Health Inc., Voluntis Inc. and WellDoc Inc.


Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Application, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered 2Morrow Inc., Canary Health Inc., Click Therapeutics Inc., Mango Health Inc. (TrialCard Incorporated), Noom Health Inc., Omada Health Inc., Pear Therapeutics, Inc., Propeller Health (ResMed), Teladoc Health Inc., Voluntis Inc. and WellDoc Inc.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter : @imarcglobal

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Global Digital Therapeutics Market to Grow at 16.8% During 2025-2033, Supported by Rising Incidences of Chronic Disorders
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials